Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Categorized | Uncategorized

Multiple Myeloma Drug Maker Celgene’s Future May Not Be Rosey

Posted on February 22 2010 by Pat Killingsworth | 1,537 views

I read an interesting business article about Celgene, makers of the mutliple myeloma drug I take, Revlimid.  You can read the article, “It’s the End of Days for Celgene’s Multiple-Myeloma Drug Franchise” written by David Phillips and posted on Feb 16, 2010 by clicking on the following link:  BNet/Celgene/Revlimid.

Feel good and keep smiling!  Pat

2 Comments For This Post

  1. Jan Says:

    Pat, thanks for the link. So does Celgene financially support centers that use the total therapy program? After reading the link, it shows how much a Revlimid maintenance program adds to the bottom line for Celgene. So are all these studies done free from Celgene's influence? Don't get me wrong, Revlimid is a great drug addition for MM.

  2. Pat Killingsworth Says:

    Hi Jan-
    Sure! Celgene thinks Total Therapy is great! Why wouldn't they… Thalomid, Revlimid or soon to be released (I hope!) pomolidamide are part of any pre-transplant/post transplant TT program. That means lots and lots of Celgene drugs used for many years. As far as studies done free from Celgene's influence… Our U.S. system is a good news/bad news situation. Drug companies pay for studies (so we, the taxpayers don't have to) good news. But the drug companies pay for the studies (possibly compromising the results (bad news) Just the way it's done. For what it's worth, I'm more bullish on Celgene's potential. Pomalidamide may be HUGE for them. That will give them a monopoly on the three main oral mm medications. With patients living so much longer the numbers do start to add up fast! I'm probably not supposed to recommend stocks (not sure what the rules are) but I would buy Celgene and Millenium and Onyx stock. These novel therapies all have possible future applications against other cancers- Pat

Leave a Reply


Follow On Twitter!

Follow HelpWithMyeloma on Twitter

Archives